del Nido P J
Department of Cardiac Surgery, Harvard Medical School, Boston, Massachusetts, USA.
Ann Thorac Surg. 1996 Jan;61(1):336-9; discussion 340-1. doi: 10.1016/0003-4975(95)01019-X.
Extracorporeal membrane oxygenation (ECMO) support for cardiac failure has been used in children since 1981 at the Children's Hospital in Pittsburgh. Most children required support after cardiac operations. Recently, however, a larger number of patients with decompensated cardiomyopathy or myocarditis have been supported with ECMO, which was used as a bridge to transplantation in most.
From 1981 to 1994, 68 children were placed on ECMO for cardiac support.
The overall survival for the entire time period was 38%, with the more recent experience survival increased to 47%. In 14 children, ECMO was used as a bridge to transplantation, with 9 children receiving a heart transplant and 7 long-term survivors. Extracorporeal membrane oxygenation has also been used to resuscitate 11 children after sudden cardiac arrest, with a long-term survival of 53%.
We conclude that ECMO support for severe cardiac failure is effective. Patient selection and the use of heart transplantation for intractable heart failure have improved the overall survival.
自1981年以来,匹兹堡儿童医院一直使用体外膜肺氧合(ECMO)支持治疗儿童心力衰竭。大多数儿童在心脏手术后需要支持。然而,最近有大量失代偿性心肌病或心肌炎患者接受了ECMO支持,其中大多数被用作移植的桥梁。
1981年至1994年,68名儿童接受了ECMO心脏支持。
整个时间段的总体生存率为38%,最近的经验使生存率提高到47%。14名儿童中,ECMO被用作移植的桥梁,9名儿童接受了心脏移植,7名长期存活。体外膜肺氧合还被用于11名心脏骤停后儿童的复苏,长期生存率为53%。
我们得出结论,ECMO支持治疗严重心力衰竭是有效的。患者选择和对难治性心力衰竭使用心脏移植提高了总体生存率。